Having worked with the Basel-based Sanofi Pharma AG and Abbott Ltd in Zug, Hans Peter Hasler’s career took him to Wyeth Group, where he held various senior management positions in Switzerland, Europe and the USA. Between 2001 and 2009, he worked for various companies in the Biogen Group, latterly as Chief Operating Officer of the US firm Biogen Idec Inc., which is based in Cambridge, USA, where he had overall responsibility for the worldwide business, business development, medical affairs and Biogen International.

At present, he is working as an independent consultant to biotech and pharmaceuticals companies. Hans Peter Hasler is Chairman of the Board of Directors of HBM BioVentures AG, Vice-Chairman of the Board of Directors of Santhera Pharmaceuticals Holding Ltd, of Acino Pharma AG and Member of the Board of Directors of Ferring Pharmaceuticals. He holds a Swiss Federal Commercial Diploma and a Marketing Manager Certificate from the Swiss Institute of Business and Economics (SIB) in Zurich.